These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 24626572

  • 1. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y.
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [Abstract] [Full Text] [Related]

  • 2. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
    Deng M, Li MH, Liu SA, Liu F, Sang Y, Song SJ, Zang SF, Guan XP, Yao X, Wu XP, Cheng J, Xu DZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):21-3. PubMed ID: 20848841
    [Abstract] [Full Text] [Related]

  • 3. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [Abstract] [Full Text] [Related]

  • 4. Beneficial therapeutic effect of Chinese herbal Bushen formula on CHB patients with mildly elevated alanine aminotransferase by down-regulating CD4+CD25+T cells.
    Li M, Sun XH, Zhou ZH, Yu Z, Jin SG, Zhu XJ, Gao YQ.
    J Ethnopharmacol; 2013 Mar 27; 146(2):614-22. PubMed ID: 23395622
    [Abstract] [Full Text] [Related]

  • 5. Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.
    Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF.
    Antimicrob Agents Chemother; 2013 Mar 27; 57(3):1304-11. PubMed ID: 23274669
    [Abstract] [Full Text] [Related]

  • 6. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
    Arasli M, Ustundag Y, Delikanli B, Harmandar F, Buyukuysal C.
    Hepatogastroenterology; 2012 May 27; 59(115):851-7. PubMed ID: 22193343
    [Abstract] [Full Text] [Related]

  • 7. Telbivudine therapy may shape CD4(+) T-cell response to prevent liver fibrosis in patients with chronic hepatitis B.
    Li J, Jia M, Liu Y, She W, Li L, Wang J, Jiang W.
    Liver Int; 2015 Mar 27; 35(3):834-45. PubMed ID: 24814578
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.
    Nan XP, Zhang Y, Yu HT, Sun RL, Peng MJ, Li Y, Su WJ, Lian JQ, Wang JP, Bai XF.
    Viral Immunol; 2012 Feb 27; 25(1):21-8. PubMed ID: 22233255
    [Abstract] [Full Text] [Related]

  • 9. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
    Zhang HH, Guo F, Fei R, Ma H, Cong X, Wei L, Chen HS.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):511-5. PubMed ID: 18649763
    [Abstract] [Full Text] [Related]

  • 10. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
    Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, Tang Z, Fu YX, Wang FS.
    J Immunol; 2006 Jul 01; 177(1):739-47. PubMed ID: 16785573
    [Abstract] [Full Text] [Related]

  • 11. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
    El-Badawy O, Sayed D, Badary MS, Abd-Alrahman ME, El-Feky MA, Thabit AG.
    Hum Immunol; 2012 Apr 01; 73(4):335-41. PubMed ID: 22342871
    [Abstract] [Full Text] [Related]

  • 12. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.
    Su ZJ, Yu XP, Guo RY, Ming DS, Huang LY, Su ML, Deng Y, Lin ZZ.
    Diagn Microbiol Infect Dis; 2013 Aug 01; 76(4):437-44. PubMed ID: 23747030
    [Abstract] [Full Text] [Related]

  • 13. Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.
    Li CZ, Hu JJ, Xue JY, Yin W, Liu YY, Fan WH, Xu H, Liang XS.
    World J Gastroenterol; 2014 Jul 28; 20(28):9486-96. PubMed ID: 25071343
    [Abstract] [Full Text] [Related]

  • 14. [Association between CD4+CD25+Foxp3+ regulatory T cells and serum transforming growth factor beta 1 in patients with chronic hepatitis B].
    Yang GL, Xu LM, Yao HY, Wang HS, Jiang XL, Li W, Wang M, Zhou BP.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 28; 17(11):831-4. PubMed ID: 19958642
    [Abstract] [Full Text] [Related]

  • 15. [The effect of telbivudine on peripheral blood CD4+CD25+ regulatory T cells and its significance in patients with chronic hepatitis B].
    Pan XC, Yang F, Chen M.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Dec 28; 16(12):885-8. PubMed ID: 19105929
    [Abstract] [Full Text] [Related]

  • 16. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
    Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang JP, Bai XF.
    Viral Immunol; 2010 Feb 28; 23(1):63-70. PubMed ID: 20121403
    [Abstract] [Full Text] [Related]

  • 17. Association of T regulatory cells with natural course and response to treatment with interferon-α in patients with chronic hepatitis B infection.
    Xu HT, Xing TJ, Li H, Ye J.
    Chin Med J (Engl); 2012 Apr 28; 125(8):1465-8. PubMed ID: 22613654
    [Abstract] [Full Text] [Related]

  • 18. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
    Fu JL, Xu DP, Shi M, Zhang H, Jin L, Tang ZR, Wang FS.
    Zhonghua Nei Ke Za Zhi; 2006 Aug 28; 45(8):642-5. PubMed ID: 17074148
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.